W
WizardMelanin
God make my neurotransmitters great inc
- Jun 26, 2025
- 754
Based on available medical literature and studies, ropinirole appears to be the medication most likely to improve delayed ejaculation associated with death grip syndrome (DGS) among the three options. DGS, while not a formal medical diagnosis, describes a form of delayed ejaculation (DE) often linked to habitual intense masturbation that desensitizes the penis, making orgasm difficult during partnered sex despite normal function during solo activity.
Treatments for DE are generally off-label, with limited high-quality evidence, and focus on addressing underlying causes like neurotransmitter imbalances. Behavioral changes (e.g., abstaining from tight-grip masturbation for 1-2 weeks and retraining sensitivity with looser stimulation or devices like fleshlights) are first-line, but pharmacological options can help in refractory cases.
Why Ropinirole?
Ropinirole is a dopamine agonist primarily used for Parkinson's disease and restless legs syndrome. Dopamine plays a key role in facilitating ejaculation by lowering the ejaculatory threshold in the central nervous system. Studies show dopamine agonists like ropinirole can reverse sexual dysfunction, including DE and impaired orgasm, especially when induced by antidepressants (which often cause DE as a side effect).df610f8a3c68
A clinical trial specifically tested ropinirole (as Requip CR) against placebo for SSRI-induced sexual dysfunction, measuring outcomes like erectile function, satisfaction, and orgasm via validated scales (e.g., International Index of Erectile Function); although results were inconclusive due to small enrollment (n=9), the intent was to counteract delays in arousal and orgasm.5ebef9 In broader reviews of DE treatments, dopamine agonists (including ropinirole) are noted for pro-sexual effects, such as hypersexuality in some users, and animal studies suggest they facilitate ejaculation by enhancing dopaminergic pathways.aa89ef For DGS specifically, where desensitization mimics medication-induced DE, ropinirole's mechanism could help resensitize responses, though evidence is from case series and retrospective data (evidence level 3-4), not large RCTs.
Typical dosing for off-label use in sexual dysfunction starts low (e.g., 0.25-1 mg/day, titrated up), but consult a doctor, as side effects include nausea, dizziness, and compulsive behaviors.
Comparison to the Others
Baclofen: This GABA agonist and muscle relaxant is sometimes listed off-label for anejaculation (complete inability to ejaculate, often in spinal cord injury), via inhibition of GABA-B receptors in the spinal cord to modulate motor nerves.dbdf24 However, evidence shows it often worsens DE: In studies of intrathecal baclofen for spasticity, it impaired ejaculation (e.g., made it disappear or more difficult in 3/3 patients who could ejaculate pre-treatment) and reduced erection quality, with effects reversible on dose reduction.6c8b03b59177 Case reports confirm higher doses cause orgasm/ejaculation difficulties in both men and women.7c5508 For DGS, baclofen would likely exacerbate delays rather than improve them, as it relaxes muscles involved in ejaculation without addressing desensitization.
Agomelatine: This antidepressant (melatonin agonist and 5-HT2C antagonist) is notable for not causing sexual dysfunction, unlike SSRIs. A 12-week study in depressed patients (n=25) showed improved depressive symptoms and sexual function scores (e.g., Arizona Sexual Experiences Scale), with gains in desire, arousal, orgasm intensity, and timing—primarily in women, with minimal but non-negative changes in men.1bf862 It's effective for switching from SD-causing antidepressants.aef242 However, it doesn't actively treat primary DE or DGS; reviews of DE pharmacotherapy don't mention it.4c111163ffe4 If your DE stems from depression, it might help indirectly by maintaining sexual response, but it's not targeted for facilitation like dopamine agonists.
None of these are FDA-approved for DE/DGS, and evidence is limited (mostly small studies or case reports). Consult a urologist or sex therapist for personalized advice, as underlying issues (e.g., anxiety, low testosterone) should be ruled out. If medication is pursued, ropinirole aligns best with established DE treatments like other dopamine agonists (e.g., cabergoline, bupropion).3ed05fd9175b
Disclaimer: Grok is not a doctor; please consult one. Don't share information that can identify you.
Treatments for DE are generally off-label, with limited high-quality evidence, and focus on addressing underlying causes like neurotransmitter imbalances. Behavioral changes (e.g., abstaining from tight-grip masturbation for 1-2 weeks and retraining sensitivity with looser stimulation or devices like fleshlights) are first-line, but pharmacological options can help in refractory cases.
Why Ropinirole?
Ropinirole is a dopamine agonist primarily used for Parkinson's disease and restless legs syndrome. Dopamine plays a key role in facilitating ejaculation by lowering the ejaculatory threshold in the central nervous system. Studies show dopamine agonists like ropinirole can reverse sexual dysfunction, including DE and impaired orgasm, especially when induced by antidepressants (which often cause DE as a side effect).df610f8a3c68
A clinical trial specifically tested ropinirole (as Requip CR) against placebo for SSRI-induced sexual dysfunction, measuring outcomes like erectile function, satisfaction, and orgasm via validated scales (e.g., International Index of Erectile Function); although results were inconclusive due to small enrollment (n=9), the intent was to counteract delays in arousal and orgasm.5ebef9 In broader reviews of DE treatments, dopamine agonists (including ropinirole) are noted for pro-sexual effects, such as hypersexuality in some users, and animal studies suggest they facilitate ejaculation by enhancing dopaminergic pathways.aa89ef For DGS specifically, where desensitization mimics medication-induced DE, ropinirole's mechanism could help resensitize responses, though evidence is from case series and retrospective data (evidence level 3-4), not large RCTs.
Typical dosing for off-label use in sexual dysfunction starts low (e.g., 0.25-1 mg/day, titrated up), but consult a doctor, as side effects include nausea, dizziness, and compulsive behaviors.
Comparison to the Others
Baclofen: This GABA agonist and muscle relaxant is sometimes listed off-label for anejaculation (complete inability to ejaculate, often in spinal cord injury), via inhibition of GABA-B receptors in the spinal cord to modulate motor nerves.dbdf24 However, evidence shows it often worsens DE: In studies of intrathecal baclofen for spasticity, it impaired ejaculation (e.g., made it disappear or more difficult in 3/3 patients who could ejaculate pre-treatment) and reduced erection quality, with effects reversible on dose reduction.6c8b03b59177 Case reports confirm higher doses cause orgasm/ejaculation difficulties in both men and women.7c5508 For DGS, baclofen would likely exacerbate delays rather than improve them, as it relaxes muscles involved in ejaculation without addressing desensitization.
Agomelatine: This antidepressant (melatonin agonist and 5-HT2C antagonist) is notable for not causing sexual dysfunction, unlike SSRIs. A 12-week study in depressed patients (n=25) showed improved depressive symptoms and sexual function scores (e.g., Arizona Sexual Experiences Scale), with gains in desire, arousal, orgasm intensity, and timing—primarily in women, with minimal but non-negative changes in men.1bf862 It's effective for switching from SD-causing antidepressants.aef242 However, it doesn't actively treat primary DE or DGS; reviews of DE pharmacotherapy don't mention it.4c111163ffe4 If your DE stems from depression, it might help indirectly by maintaining sexual response, but it's not targeted for facilitation like dopamine agonists.
None of these are FDA-approved for DE/DGS, and evidence is limited (mostly small studies or case reports). Consult a urologist or sex therapist for personalized advice, as underlying issues (e.g., anxiety, low testosterone) should be ruled out. If medication is pursued, ropinirole aligns best with established DE treatments like other dopamine agonists (e.g., cabergoline, bupropion).3ed05fd9175b
Disclaimer: Grok is not a doctor; please consult one. Don't share information that can identify you.
